UnitedHealth Group Inc (NYSE:UNH) declared a quarterly dividend on Wednesday, February 14th, RTT News reports. Shareholders of record on Friday, March 9th will be paid a dividend of 0.75 per share by the healthcare conglomerate on Tuesday, March 20th. This represents a $3.00 dividend on an annualized basis and a yield of 1.32%.
UnitedHealth Group has increased its dividend by an average of 27.0% per year over the last three years and has increased its dividend annually for the last 8 consecutive years. UnitedHealth Group has a dividend payout ratio of 30.0% indicating that its dividend is sufficiently covered by earnings. Research analysts expect UnitedHealth Group to earn $14.01 per share next year, which means the company should continue to be able to cover its $3.00 annual dividend with an expected future payout ratio of 21.4%.
UnitedHealth Group (UNH) traded up $0.47 during mid-day trading on Wednesday, hitting $227.11. The stock had a trading volume of 434,812 shares, compared to its average volume of 4,175,031. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.70 and a current ratio of 0.73. The firm has a market cap of $219,630.00, a P/E ratio of 23.94, a P/E/G ratio of 1.32 and a beta of 0.70. UnitedHealth Group has a one year low of $156.49 and a one year high of $250.79.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 198 shares of the stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the completion of the transaction, the director now owns 1,790,567 shares in the company, valued at approximately $434,302,025.85. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director William C. Ballard, Jr. sold 10,000 shares of the stock in a transaction dated Tuesday, January 23rd. The stock was sold at an average price of $246.38, for a total value of $2,463,800.00. Following the transaction, the director now owns 76,637 shares of the company’s stock, valued at approximately $18,881,824.06. The disclosure for this sale can be found here. In the last quarter, insiders have sold 53,396 shares of company stock valued at $12,262,067. Corporate insiders own 0.89% of the company’s stock.
A number of hedge funds have recently added to or reduced their stakes in UNH. Arrowstreet Capital Limited Partnership grew its holdings in shares of UnitedHealth Group by 30.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,303,068 shares of the healthcare conglomerate’s stock valued at $241,615,000 after acquiring an additional 300,744 shares in the last quarter. Bank of Nova Scotia grew its holdings in shares of UnitedHealth Group by 7.8% in the 2nd quarter. Bank of Nova Scotia now owns 447,793 shares of the healthcare conglomerate’s stock valued at $83,030,000 after acquiring an additional 32,405 shares in the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of UnitedHealth Group by 6.5% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 367,044 shares of the healthcare conglomerate’s stock valued at $68,070,000 after acquiring an additional 22,428 shares in the last quarter. Castleark Management LLC grew its holdings in shares of UnitedHealth Group by 4.2% in the 2nd quarter. Castleark Management LLC now owns 306,486 shares of the healthcare conglomerate’s stock valued at $56,829,000 after acquiring an additional 12,226 shares in the last quarter. Finally, Piedmont Investment Advisors LLC grew its holdings in shares of UnitedHealth Group by 2.4% in the 2nd quarter. Piedmont Investment Advisors LLC now owns 241,736 shares of the healthcare conglomerate’s stock valued at $44,823,000 after acquiring an additional 5,702 shares in the last quarter. Hedge funds and other institutional investors own 86.00% of the company’s stock.
UNH has been the topic of a number of analyst reports. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price target on the stock in a research note on Saturday, January 20th. Goldman Sachs Group initiated coverage on UnitedHealth Group in a research note on Wednesday, January 3rd. They issued a “buy” rating and a $269.00 price target on the stock. Morgan Stanley increased their price target on UnitedHealth Group from $215.00 to $235.00 and gave the company an “overweight” rating in a research note on Wednesday, October 18th. Credit Suisse Group increased their price target on UnitedHealth Group from $252.00 to $260.00 and gave the company an “outperform” rating in a research note on Wednesday, January 17th. Finally, Bank of America increased their price target on UnitedHealth Group from $230.00 to $240.00 and gave the company a “buy” rating in a research note on Wednesday, October 18th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the company’s stock. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $243.22.
TRADEMARK VIOLATION WARNING: This report was originally published by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was copied illegally and reposted in violation of international trademark & copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2018/02/14/unitedhealth-group-inc-unh-to-issue-quarterly-dividend-of-0-75.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.